Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | ARGX | BNTX | ||
| Company | Alnylam Pharmaceuticals | Argenx Se ADR | Biontech Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 262.18 | 598.41 | 112.90 | ||
| High | 262.83 | 601.17 | 115.93 | ||
| Low | 256.75 | 590.60 | 102.14 | ||
| Last | 257.91 | 595.04 | 103.56 | ||
| Change | -6.69 | -4.31 | -7.92 | ||
| % Change | -2.53% | -0.72% | -7.10% | ||
| Volume | 648,169 | 591,488 | 1,698,535 | ||
| 20-Day Average Volume | 884,508 | 272,934 | 864,937 | ||
| Previous Close | 264.60 | 599.35 | 111.48 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 279.03 | 577.28 | 110.42 | ||
| 20-Day Raw Stochastic | 2.62% | 76.35% | 10.30% | ||
| 20-Day Relative Strength | 40.63% | 61.06% | 42.61% | ||
| Weighted Alpha | +29.83 | +39.87 | -9.00 | ||
| Today's Opinion | 40% Buy | 100% Buy | 40% Buy | ||
| Previous Opinion | 40% Buy | 100% Buy | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.26% since 11/07/24 | +0.61% since 11/07/24 | -4.00% since 11/07/24 | ||
| Low | 256.75 on 11/14/24 | 586.59 on 11/12/24 | 102.14 on 11/14/24 | ||
| High | 286.58 on 11/11/24 | 603.22 on 11/13/24 | 115.93 on 11/14/24 | ||
| 1-Month | |||||
| %Chg | -8.97% since 10/14/24 | +9.47% since 10/14/24 | -13.80% since 10/14/24 | ||
| Low | 256.75 on 11/14/24 | 537.68 on 10/16/24 | 102.14 on 11/14/24 | ||
| High | 304.39 on 10/17/24 | 611.22 on 11/05/24 | 119.86 on 10/15/24 | ||
| 3-Month | |||||
| %Chg | -1.89% since 08/14/24 | +13.91% since 08/14/24 | +22.05% since 08/14/24 | ||
| Low | 244.88 on 09/06/24 | 511.19 on 08/27/24 | 82.46 on 08/16/24 | ||
| High | 304.39 on 10/17/24 | 611.22 on 11/05/24 | 131.49 on 09/17/24 | ||
| 6-Month | |||||
| %Chg | +74.39% since 05/14/24 | +67.14% since 05/14/24 | +12.22% since 05/14/24 | ||
| Low | 144.73 on 05/16/24 | 356.38 on 05/21/24 | 76.53 on 08/05/24 | ||
| High | 304.39 on 10/17/24 | 611.22 on 11/05/24 | 131.49 on 09/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 34,128,376 | 35,838,732 | 26,726,218 | ||
| Shares Outstanding, K | 128,981 | 59,796 | 239,740 | ||
| Annual Sales | 1,828,290,000 | 1,268,590,000 | 4,133,300,000 | ||
| Annual Net Income | -440,240,000 | -295,050,000 | 1,006,860,000 | ||
| Last Quarter Sales | 500,920,000 | 588,880,000 | 1,368,780,000 | ||
| Last Quarter Net Income | -111,570,000 | 91,410,000 | 217,830,000 | ||
| 60-Month Beta | 0.39 | 0.61 | 0.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.50 on 10/31/24 | 1.39 on 10/31/24 | 0.89 on 11/04/24 | ||
| Latest Earnings Date | 10/31/24 | 10/31/24 | 11/04/24 | ||
| Most Recent Dividend | N/A | N/A | 3.084 on 06/02/22 | ||
| Next Ex-Dividends Date | N/A | N/A | 06/02/22 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||